BDBM350534 N-(4-chlorophenyl)-2-(4,4-diethyl- 2,5-dioxoimidazolidin-1-yl)acetamide::US10208071, Table 3.10::US10799518, Structure TABLE 3.10

SMILES CCC1(CC)NC(=O)N(CC(=O)Nc2ccc(Cl)cc2)C1=O

InChI Key InChIKey=QJCHCMGTTSZGEE-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 350534   

TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350534(N-(4-chlorophenyl)-2-(4,4-diethyl- 2,5-dioxoimidaz...)
Affinity DataEC50:  314nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350534(N-(4-chlorophenyl)-2-(4,4-diethyl- 2,5-dioxoimidaz...)
Affinity DataEC50:  3.14E+5nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In DepthDetails US Patent